NCT01578993CompletedNot Applicable
A Phase IV, Prospective Clinical Evaluation of Complications Related to the Use of Peripherally Inserted Central Catheters (PICC) - An Observational Baseline Multicenter Study.
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Teleflex
- Enrollment
- 101
- Locations
- 1
- Primary Endpoint
- Rate of PICC Line Occlusions
Study Overview
Brief Summary
The purpose of this study is to determine the rate and timing of interventions and complications related to the use of peripherally inserted central venous catheters in adult patients.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male or Female Age > 18 years requiring central venous access
- •Ability to comply with study requirements
- •Written Informed Consent
Exclusion Criteria
- •Previous enrollment in study
- •Current or recent upper extremity thrombosis, occlusion or stenosis
- •Previous axillary lymph node dissection
- •Skin inflammatory condition or rashes within 15 cm from insertion site
- •Pre-existing history of hypercoagulability unrelated to malignant disease
- •Participating in trial involving antithrombotic, anticoagulant or anti- infective drug therapies
- •Positive blood culture within 48 hours from planned PICC placement
- •Known, renal insufficiency with chronic creatinine levels > 1.7 mg/dl
Outcomes
Primary Outcomes
Rate of PICC Line Occlusions
Time Frame: Insertion to Removal / maximum 3 months
The incidence, severity and management of PICC line occlusions were recorded for each of the enrolled subjects.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple SclerosisRelapsing Remitting Multiple SclerosisNCT00367484Merck KGaA, Darmstadt, Germany460
Terminated
Not Applicable
Study of Prognostic Factors in Interventional RhythmologyCardiac SurgeryNCT03099057University Hospital, Brest2,805
Completed
Not Applicable
Immediate Verses Delayed Surgical Periodontal Therapy After Endodontic Treatment in Endo Perio Lesion With CommunicationAttachment LossTooth,Non VitalNCT02630745Postgraduate Institute of Dental Sciences Rohtak40
Active, not recruiting
Phase 1
A phase IV interventional study to assess the disease-modifying effect of long-term treatment with tildrakizumab in adult patients with moderate-to-severe plaque psoriasisModerate to severe plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2019-003218-15-PLAlmirall S.A.47
Completed
Phase 4
Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.AstigmatismNCT01885780Technolas Perfect Vision GmbH45
